IMCgp100 in Advanced Unresectable Melanoma
NCT01209676
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
1
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Advanced Disease
Unresectable
Interventions
DRUG:
IMCgp100 injection
Sponsor
University of Pennsylvania